Brief: Respiri Says U.S. Tariffs On Chinese Medical Devices Have Minimal Impact On Respiri
09/04/2025 02:32
April 9 (Reuters) - Respiri Ltd RSH.AX: U.S. TARIFFS ON CHINESE MEDICAL DEVICES HAVE MINIMAL IMPACT ON RESPIRI EXPECTED US TARIFF-RELATED COST INCREASES WILL BE ABSORBED BY RESPIRI Further company coverage: RSH.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vitasora Health
See all newsBrief: Vitasora Health Raises A$4 Million In Placement
Brief: Vitasora Health Seeks Trading Halt
Australia's Vitasora Health soars on extending deal with Evolent Care Partners
Brief: Vitasora Health Posts Quarterly Revenue Of A$1.12 MLN
Australia's Vitasora Health hits over 2-month low on discounted placement